Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $8.74 | Prev. Close $8.65 | Circuit Range N/A |
Day Range $8.35 - $8.85 | Year Range $6.13 - $11.96 | Volume 2,91,340 |
Average Traded $8.53 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $8.74 | $8.68 | +0.00% |
09-Jun-26 | $8.74 | $8.68 | +0.81% |
08-Jun-26 | $9.56 | $8.61 | -9.18% |
05-Jun-26 | $10.01 | $9.48 | -6.78% |
04-Jun-26 | $10.26 | $10.17 | -0.39% |
03-Jun-26 | $10.10 | $10.21 | +0.00% |
02-Jun-26 | $10.35 | $10.21 | -2.95% |